Contact us

Please reach out to us with inquiries. A member of the NuView team will be in touch.

Reach Out

We'd love to hear from you

Questions about our technology, pipeline, partnerships, or anything else? Fill out the form and we'll respond as soon as possible.

HeadquartersNuView Life Sciences, Inc.
10171 Silva Road, San Diego, CA 92021

By submitting, you agree to be contacted by NuView Life Sciences. We respect your privacy.

Investor Relations

For investors & strategic partners

For due-diligence materials, the NV-VPAC1 white paper, and partnership discussions, NuView welcomes conversations with investors and strategic partners. Reach out and we'll follow up directly.

Email Investor Relations

Prefer email updates? Use the white-paper request in the form above and we'll keep you posted.

Available on request

  • The NV-VPAC1 white paper and scientific dossier
  • Peer-reviewed publications and human imaging data
  • Pipeline, IP estate, and regulatory status (FDA Pre-IND)
  • Platform expansion roadmap across indications
$30B+global breast cancer market — larger than prostate & neuroendocrine tumors combined
~$9Binvested in radioligand therapy over 24 months — none directed at breast cancer

Market figures: industry analyst estimates.